Sort
23,748 grants matching “melanoma”
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
$483,693Michael A Teitell · University Of California Los Angeles · R01 · FY2015 · CA
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$483,665Edward John Usherwood · Dartmouth College · R01 · FY2023 · CA
IMPROVING THE DIAGNOSIS OF MELANOMA AND PRECURSOR LESIONS AMONG VETERANS: DEVELOPING AI TECHNIQUES AND TELEDERMATOPATHOLOGY. NEW AWARD.
$483,613University Of Washington · · FY2020 · Defense Health Agency
Targeting autophagy to enhance immune checkpoint inhibition
$483,579Ravi K Amaravadi · Wistar Institute · P50 · FY2025 · CA
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$483,484Periasamy Selvaraj · Emory University · R01 · FY2018 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$483,437Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Targeting PPT1 in the Tumor Microenvironment
$483,340Ravi K Amaravadi · Wistar Institute · P01 · FY2021 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$483,338Richard J. Hodes · Basic Sciences · Z01 · FY2007 · CA
Development of a fast scanning, extended field-of-view multiphoton microscope for clinical skin imaging
$483,207Mihaela Balu · University Of California-Irvine · R01 · FY2020 · EB
An Internet-Based Behavioral Intervention for Individuals Diagnosed with Melanoma
$483,098Sharon L Manne · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA
Project 3: Identifying transcriptional driver genes and targeting transcription in TSC
$482,742David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2022 · CA
HTS for Direct Targeting of the Transcription Factor MITF
$482,741Min Guo · Scripps Florida · R01 · FY2014 · CA
Rare Cancer Genetics Registry
$482,649Dianne M Finkelstein · Massachusetts General Hospital · R01 · FY2014 · CA
Randomized Trial of a Social Media-Delivered Intervention Targeting Indoor Tanning Users
$482,609Jerod L Stapleton · Rbhs -Cancer Institute Of New Jersey · R01 · FY2017 · CA
Chronic Mitochondrial Division and Melanoma: Mechanism, Prognosis, and Therapy
$482,562Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Mechanisms of cancer mutations
$482,549Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2025 · CA
Mechanisms of cancer mutations
$482,549Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2023 · CA
MDA-7/IL-24: Therapy of Prostate Cancer
$482,536Paul B Fisher · Virginia Commonwealth University · P01 · FY2008 · CA
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$482,531Antoni Ribas · California Institute Of Technology · P01 · FY2010 · CA
Molecular Epidemiology of Melanoma
$482,431University Of Pennsylvania · R01 · FY2004 · CA
0-glycoprotein podoplanin in vascular development
$482,413Lijun Xia · Oklahoma Medical Research Foundation · P01 · FY2011 · HL
Regulation of metastatic progression by an endothelial-derived factor
$482,370Sohail F. Tavazoie · Rockefeller University · R01 · FY2019 · CA
Project 1: Targeted therapeutics for pediatric low-grade glioma
$482,362Benjamin Harris Kann · Brigham And Women'S Hospital · P50 · FY2024 · CA
Targeting PPT1 in the Tumor Microenvironment
$482,190Ravi K Amaravadi · Wistar Institute · P01 · FY2019 · CA
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$482,114Periasamy Selvaraj · Emory University · R01 · FY2017 · CA